Progress of personalized medicine of cystic fibrosis in the times of efficient CFTR modulators

Burkhard Tümmler(Medizinische Hochschule Hannover), Marcus Mall(German Centre for Cardiovascular Research)

Molecular and Cellular Pediatrics

May 5, 2025

10.1186/s40348-025-00194-0

Cited by 11

Related Papers

SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19

|Nature|2020|1.4k

Complete genome sequence and comparative analysis of the metabolically versatile <i>Pseudomonas putida</i> KT2440

|Environmental Microbiology|2002|1.4k

Cross-reactive CD4 <sup>+</sup> T cells enhance SARS-CoV-2 immune responses upon infection and vaccination

|Science|2021|315

Presence of SARS-CoV-2-reactive T cells in COVID-19 patients and healthy donors

|medRxiv|2020|178

Conditional deletion of Nedd4-2 in lung epithelial cells causes progressive pulmonary fibrosis in adult mice

|Nature Communications|2020|107